183 related articles for article (PubMed ID: 16360393)
1. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
Podnos YD; Smith D; Wagman LD; Ellenhorn JD
Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
[TBL] [Abstract][Full Text] [Related]
2. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
3. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
5. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Zaydfudim V; Feurer ID; Griffin MR; Phay JE
Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
[TBL] [Abstract][Full Text] [Related]
6. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
Haigh PI; Urbach DR
Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
[TBL] [Abstract][Full Text] [Related]
7. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
9. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
10. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
12. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
13. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
Brierley J; Tsang R; Panzarella T; Bana N
Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma in a juvenile patient.
Khan MU; Nawaz MK; Saadullah M; Syed AA; Hussain R; Azhar R; Shah MA
Clin Nucl Med; 2008 May; 33(5):319-20. PubMed ID: 18431142
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
18. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.
Besic N; Auersperg M; Golouh R
Eur J Surg Oncol; 1999 Dec; 25(6):599-605. PubMed ID: 10556007
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in well-differentiated thyroid carcinoma.
Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
